《全日總結》恆指升405點 美團漲逾4% 港交所受捧
美國總統拜登與跨黨派參議員會面後宣佈雙方達成基建撥款協議，美國股市昨晚(24日)造好，納指標指創收市新高。恆指今早高開120點已重上兩萬九點，走勢持續向好，最多升422點一度高見29,305點，全日收升405點或1.4%，報29,288；國指升201點或1.9%，報10,878點。恆生科技指數升195點或2.4%，報8,235點。大市全日成交總額1,570.49億元。滬、深港通南下交易全日分別錄得淨流入22.46億元及27.29億元人民幣。
科技股普遍造好，騰訊(00700.HK)升2.7%報598.5元，美團(03690.HK)更升4.8%，阿裏巴巴(09988.HK)續升2.6%。快手(01024.HK)股價彈高8%，「B站」嗶哩嗶哩(09626.HK)亦上揚7.4%。軟件業務股造好，金碟國際(00268.HK)、金山軟件(03888.HK)、中國軟件國際(00354.HK)升2.4%至3.8%。舜宇(02382.HK)則逆市跌1.6%。
中資電訊股有好表現，中移動(00941.HK)、聯通(00762.HK)分別升2.5%、2.1%。GIC斥1.42億元增持中電信(00728.HK)，刺激股價升8.5%。港交所(00388.HK)升3%。匯控(00005.HK)升0.4%，友邦保險(01299.HK)無升跌。百威亞太(01876.HK)亦升4.3%。
內銀股靠穩，工行(01398.HK)無升跌，建行(00939.HK)升0.5%。資源股造好，江西銅(00358.HK)、中鋁(02600.HK)、洛鉬(03993.HK)升4.4%-6.3%。中石油(00857.HK)參股崑崙資本29%，全日股價升3.2%。
藥明生物(02269.HK)及藥明康德(02359.HK)造好，分別升2.5%及3.3%；東陽光藥(01558.HK)兩產品集中採購擬中選，股價揚11.6%。三生製藥(01530.HK)全日股價挫16.6%，今早有近2.3億股大手上板。
六福集團(00590.HK)截至3月底止全年度盈利按年增長17.43%，全日股價漲12.7%。互太紡織(01382.HK)全年純利7.21億元跌3%，全日股價挫6.4%，花旗指互太紡織2021下全財年毛利率僅錄15%表現遜預期。
衆安集團(00672.HK)建議通過附屬衆安智慧獨立上主板，刺激股價揚8.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
